Wednesday, April 29, 2026

Study Details | NCT07506044 | Dexmedetomidine as an Adjuvant During Dural Puncture Epidural


In continuation of my update on Dexmedetomidine




Study Overview

Brief Summary:

The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.

Detailed Description
The primary efficacy point is the total dose of bupivacaine administered during labor. The secondary endpoints include the VAS pain scores, number of administered additional doses, incidence of motor block, delivery type (spontaneous vaginal or cesarean), maternal satisfaction, and complications such as hypotension, fetal bradycardia, and epidural-related maternal fever.

Official Title

The Effect of Different Doses of Dexmedetomidine as an Adjuvant to Bupivacaine for Parturients Having Dural Puncture Epidural Technique to Elaborate Labor Pain.

https://en.wikipedia.org/wiki/Dexmedetomidine

Read more :